Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf

Por um escritor misterioso
Last updated 22 dezembro 2024
Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf
Beckwith-Wiedemann syndrome (BWS) is a growth disorder variably characterized by macroglossia, hemihyperplasia, omphalocele, neonatal hypoglycemia, macrosomia, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), visceromegaly, adrenocortical cytomegaly, kidney abnormalities (e.g., medullary dysplasia, nephrocalcinosis, and medullary sponge kidney), and ear creases / posterior helical ear pits. BWS is considered a clinical spectrum, in which affected individuals may have many or only one or two of the characteristic clinical features. Although most individuals with BWS show rapid growth in late fetal development and early childhood, growth rate usually slows by age seven to eight years. Adult heights are typically within the normal range. Hemihyperplasia (also known as lateralized overgrowth) is often appreciated at birth and may become more or less evident over time. Hemihyperplasia may affect segmental regions of the body or selected organs and tissues. Hemihyperplasia may be limited to one side of the body (ipsilateral) or involve opposite sides of the body (contralateral). Macroglossia is generally present at birth and can obstruct breathing or interfere with feeding in infants. Neonatal hypoglycemia occurs in approximately 50% of infants with BWS; most episodes are mild and transient. However, in some cases, persistent hypoglycemia due to hyperinsulinism may require consultation with an endocrinologist for therapeutic intervention. With respect to the increased risk for embryonal tumor development, the risk for Wilms tumor appears to be concentrated in the first seven years of life, whereas the risk for developing hepatoblastoma is concentrated in the first three to four years of life. Cognitive and neurobehavioral development is usually normal. After childhood, prognosis is generally favorable, although some adults experience issues requiring medical management (e.g., for renal or skeletal concerns).
Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf
Beckwith-Wiedemann syndrome: Causes, symptoms, treatment, and more
Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf
Overgrowth syndromes — clinical and molecular aspects and tumour
Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf
Characterization of the Beckwith‐Wiedemann spectrum: Diagnosis and
Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf
Characterization of the Beckwith‐Wiedemann spectrum: Diagnosis and
Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf
Beckwith–Wiedemann and IMAGe syndromes: two very different disea
Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf
Nevoid Basal Cell Carcinoma Syndrome - GeneReviews® - NCBI Bookshelf
Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf
Beckwith-Weidemann syndrome with IC2 (KvDMR1) hypomethylation
Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf
Beckwith-Weidemann syndrome with IC2 (KvDMR1) hypomethylation
Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf
A clinical and molecular investigation of two South African
Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf
Beckwith-Wiedemann Syndrome Resources
Beckwith-Wiedemann Syndrome - GeneReviews® - NCBI Bookshelf
Beckwith-Weidemann syndrome with IC2 (KvDMR1) hypomethylation

© 2014-2024 immanuelipc.com. All rights reserved.